Page 14
PROSTATE CANCER
Autopsy evidence indicates that prostate cancer is histologically evident in up to 34% of men aged 40-49 and up to 70% of men aged 80 and older. Most men however, never progress to clinically diagnosed disease.
In a study of 20 men with metastatic hormone-refractory prostate cancer each received 10 mg of lycopene for three months. One patient achieved a complete response Six patients had a partial response and alleviation of other symptoms as bone response if present. The disease remained stable in 10 patients and progressed in three.
A UCLA study showed men with the highest dietary intake of boron reduced their prostate dancer risk by 54% compared to men with the lowest boron intake. Boron at doses of 6 to 15 mg. may become an effective adjuvant therapy.
Numerous studies over the two years have identified specific mechanisms by which Curcumin inhibits the growth of prostate cancer cells and then activates genes that tell cancer cells to self-destruct.
A group of 29 men scheduled to undergo surgical removal of the prostate were put on a 50-gram soy bread supplement or a 50-gram wheat supplement. The soy group saw a 12.7% reduction in PSA levels, whereas the wheat group experienced a 40% in PSA.
Men with the lowest levels of selenium in their blood were four times more likely to develop prostate cancer than those with normal levels. Blood levels of this trace element decline with age. Men 60 or older should ask their doctor about taking a 200-microgram selenium supplement daily. Journal of Urology
For the past several years European doctors have been routinely prescribing Saw palmetto, pygeum and nettle root extracts for benign prostate enlargement (BPH). Beta-sitosterol seems to help benign prostate enlargement and decrease the growth of human prostate cancer
|
